Literature DB >> 24913299

Angiocentric Glioma: The Infiltrative Glioma with Ependymal Differentiation.

Ayca Ersen1, M Serefettin Canda, Suleyman Men, Kemal Yucesoy, Orhan Kalemci, Tulay Canda.   

Abstract

Angiocentric glioma is an epileptogenic, infiltrative, low grade glial tumor, with ependymal and astrocytic differentiation, most commonly seen in young adults and the pediatric age group. Herein we report a case of 21-year-old male patient who presented with fever and pharmaco-resistant seizures. Computed tomography revealed an iso-dense mass lesion in the gyrus rectus of the left frontal lobe. On magnetic resonance imaging the mass was hyperintense on both T1- and T2-weighted images with no contrast enhancement. Histopathological examination revealed monomorphous tumor cells diffusely infiltrating the neuropil with circumferential, radial, or longitudinal angiocentric alignment and subpial aggregation with perpendicular alignment of the cells to the pial surface. Among central nervous system tumors with ependymal differentiation, this distinct entity is the one with an infiltrating growth pattern. In spite of the infiltrating pattern, it does not seem to have a potential for aggressive behavior.

Entities:  

Mesh:

Year:  2017        PMID: 24913299     DOI: 10.5146/tjpath.2014.01262

Source DB:  PubMed          Journal:  Turk Patoloji Derg        ISSN: 1018-5615


  3 in total

Review 1.  Radiohistogenomics of pediatric low-grade neuroepithelial tumors.

Authors:  Asim K Bag; Jason Chiang; Zoltan Patay
Journal:  Neuroradiology       Date:  2021-03-29       Impact factor: 2.804

2.  Clinical characteristics, treatment and prognosis of angiocentric glioma.

Authors:  Guoqing Han; Junsi Zhang; Yue Ma; Qiuping Gui; Shi Yin
Journal:  Oncol Lett       Date:  2020-06-10       Impact factor: 2.967

Review 3.  Neuroimaging features of angiocentric glioma: A case series and systematic review.

Authors:  Ryo Kurokawa; Akira Baba; Pinarbasi Emile; Mariko Kurokawa; Yoshiaki Ota; John Kim; Aristides Capizzano; Ashok Srinivasan; Toshio Moritani
Journal:  J Neuroimaging       Date:  2022-02-24       Impact factor: 2.324

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.